Free SAS Institute A00-282 Exam Questions
Try our Free Demo Practice Tests for Comprehensive A00-282 Exam Preparation
-
SAS Institute A00-282 Exam Questions
-
Provided By: SAS Institute
- Exam: Clinical Trials Programming Using SAS 9.4
- Certification: SAS Programming Fundamentals
-
Total Questions: 145
-
Updated On: Nov 11, 2024
-
Rated: 4.9 |
-
Online Users: 290
-
Question 1
-
A pharmaceutical company is preparing submission materials for a new drug application. One of the key documents required by regulatory authorities is define.xml. Which of the following best describes the purpose of the define.xml file?
Answer: B
-
A pharmaceutical company is preparing submission materials for a new drug application. One of the key documents required by regulatory authorities is define.xml. Which of the following best describes the purpose of the define.xml file?
-
Question 2
-
In a clinical study report using SAS, you need to capture attributes such as style elements associated with a Kaplan-Meier survival plot generated by PROC LIFETEST. You've enabled ODS TRACE. After running the procedure, which output object listed in the ODS trace output would you look into for the survival plot details?
Answer: C
-
In a clinical study report using SAS, you need to capture attributes such as style elements associated with a Kaplan-Meier survival plot generated by PROC LIFETEST. You've enabled ODS TRACE. After running the procedure, which output object listed in the ODS trace output would you look into for the survival plot details?
-
Question 3
-
A clinical trials programmer is tasked with creating a Kaplan-Meier survival plot with a log-rank test for comparing survival curves between two treatment groups. The dataset includes patient ID, treatment group, time to event or censor, and the event indicator. Which PROC step will they likely use to produce the required output?
Answer: A
-
A clinical trials programmer is tasked with creating a Kaplan-Meier survival plot with a log-rank test for comparing survival curves between two treatment groups. The dataset includes patient ID, treatment group, time to event or censor, and the event indicator. Which PROC step will they likely use to produce the required output?
-
Question 4
-
A clinical trial dataset contains multiple records per subject due to repeated measurements over time. You are tasked with summarizing the number of adverse events (AE) experienced by each subject, categorized by severity (Mild, Moderate, Severe), while accounting for the visit at which the event occurred. Which SAS procedure will allow you to obtain a summarized count of AEs by severity for each visit for all subjects?
Answer: D
-
A clinical trial dataset contains multiple records per subject due to repeated measurements over time. You are tasked with summarizing the number of adverse events (AE) experienced by each subject, categorized by severity (Mild, Moderate, Severe), while accounting for the visit at which the event occurred. Which SAS procedure will allow you to obtain a summarized count of AEs by severity for each visit for all subjects?
-
Question 5
-
A clinical trial analyst needs to create a Kaplan-Meier survival plot to visualize the time-to-event data for different treatment groups. Which PROC step should the analyst use, and what is the key statement to differentiate the treatment groups in the graph?
Answer: B
-
A clinical trial analyst needs to create a Kaplan-Meier survival plot to visualize the time-to-event data for different treatment groups. Which PROC step should the analyst use, and what is the key statement to differentiate the treatment groups in the graph?